INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Volume And Viscosity Barriers In Biologic Formulations
Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.
-
Quicker Development Using Cell Line Integration, End-To-End Support
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
Quality By Design: The Importance Of Reference Standards In Drug Development
Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.
-
Cell Retention Technology And Specialized Cell Culture Media
Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.
-
Native SEC-MALS Characterization Using A Chromatography Data System5/7/2026
Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.
-
Accelerating Method Development And Manufacturing Of GLP-1 Analogs7/29/2025
Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.
-
Mobile Minor Process Explanation4/28/2026
Dr. Jordan Potts explains how the Mobile Minor spray dryer works and outlines its role in spray drying and particle engineering research applications.
-
Simplify Process Scale-Up With An Innovative Single-Use Bioreactor10/15/2025
Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.
-
The Top Tech Transfer Risks At Multi-Site CDMOs3/31/2026
Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
DRUG DEVELOPMENT SOLUTIONS
-
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.
-
Enhance your protein production with a next-generation feed specifically designed to boost the performance of CHO-K1 GS cell lines.
-
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
Integrate an automated cell imaging system with high-resolution imaging and robust analytics into your processes to streamline workflows for fluorescence and brightfield assays.
-
Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.